CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Macleods Pharmaceuticals Limited recalls Olanzapine Tablets

Read the official FDA notice

Published
30 Sept 2026
Units affected
22,032 30-count bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.

Brand / company
Macleods Pharmaceuticals Limited
Codes / lots
Lot: BOB22321A, Exp 07-31-2027.
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.